Article Information
History
- December 8, 2024.
Article Versions
- Version 1 (November 29, 2024 - 14:17).
- You are currently viewing Version 2 of this article (December 8, 2024 - 16:44).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Robert T Brooke1,†,
- Thomas Kocher2,3,*,†,
- Roland Zauner2,
- Juozas Gordevicius1,
- Milda Milčiūtė1,
- Marc Nowakowski3,
- Christian Haser5,
- Thomas Blobel5,
- Johanna Sieland5,
- Daniel Langhoff6,
- Winfried Banzer5,7,
- Steve Horvath1,8,‡ and
- Florian Pfab3,4,5,9,10,‡
- 1Epigenetic Clock Development Foundation, Torrance, CA, USA
- 2EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria
- 3DNAthlete Austria GmbH, 5020 Salzburg, Austria
- 4DNAthlete AG, 9494 Schaan, Lichtenstein
- 5Eintracht Frankfurt Fußball AG, 60528 Frankfurt am Main, Germany
- 6Eurofins Genomics Europe, Brendstrupgaardsvej 23, DK-8200 Aarhus N
- 7Division of Preventive and Sports Medicine, Institute of Occupational, Social and Environmental Medicine, Goethe University Frankfurt, Frankfurt/Main, Germany
- 8Altos Labs, Cambridge, UK
- 9Technische Universitaet Munich, Munich, Germany
- 10Brighton & Hove Albion Football Club, Brigthon, UK
- ↵*Correspondence: Thomas Kocher, DNAthlete Austria GmbH, 5020 Salzburg, Austria, thomas.kocher{at}dnathlete.li.
↵† These authors contributed equally to this work.